Improved outcome of acute myeloid leukaemia in Down's syndrome. - Wikidata - awgldk - TriplyDB

Improved outcome of acute myeloid leukaemia in Down's syndrome.

Improved outcome of acute myeloid leukaemia in Down's syndrome.

http://www.wikidata.org/entity/Q33662916

about

Erythroleukaemia in the north of England: a population based study Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature Review Haematology of Down syndrome Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421.Malignancy in children with trisomy 21.Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.

P2860

Q28209576-8597BC8F-B879-4F23-A088-849172A2BDAB Q35271236-60819566-A2E1-4A90-8D45-22083E97A161 Q35888110-913210B4-ADF1-47E4-AC85-A89D5B047741 Q36931357-60832E8D-07ED-42BB-9041-51FC4182EA51 Q37059586-F68D005A-A643-43B5-A1E6-6453A9B5E80E Q37379570-665B54AC-84F0-40FF-84AB-B4EEA40B61B8 Q46158135-7C028546-B689-4739-BFFC-51EE2B201908 Q46513852-59A3D033-8A0E-4603-8960-D3731A46012F

P2860

Improved outcome of acute myeloid leukaemia in Down's syndrome.

http://www.wikidata.org/entity/Q33662916

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Improved outcome of acute myeloid leukaemia in Down's syndrome.

@ast

Improved outcome of acute myeloid leukaemia in Down's syndrome.

@en

type

label

Improved outcome of acute myeloid leukaemia in Down's syndrome.

@ast

Improved outcome of acute myeloid leukaemia in Down's syndrome.

@en

prefLabel

Improved outcome of acute myeloid leukaemia in Down's syndrome.

@ast

Improved outcome of acute myeloid leukaemia in Down's syndrome.

@en

P1433

Q33662916-39B6DB9C-0729-4DD4-ADAF-0536FA753F8D

P1476

Q33662916-28A0A61E-3910-405E-8243-0681209B105F

P2093

Q33662916-1607C378-A20E-4F82-82AE-6FE4E86C60FA

Q33662916-582AF78F-DCD1-4B44-9D30-AE78E6DDA212

Q33662916-87B638DB-C359-4435-8CEE-58EF8F37D08D

Q33662916-A9F41B71-8ADF-4F7D-A831-35E4252E067A

Q33662916-E295267C-9AED-4E3D-B2C4-EC969744DA26

P2860

Q33662916-0418FB3C-3BCA-4131-B515-A714DEB86248

Q33662916-0B6B40D7-B64D-435F-8161-D8A95CAB59F6

Q33662916-184D8698-7391-4312-9DE8-3079CFEE6E39

Q33662916-259DA684-FDC8-45AB-B2D8-6BAFF741F06E

Q33662916-3115614B-6CBB-49C1-BAF1-12A429A258FC

Q33662916-4146E0AC-46E8-4131-BBBF-E4B14094206D

Q33662916-56796DEB-9F83-420D-9DB4-D72BF7696AF0

Q33662916-5D520906-1F29-4DF1-B1BC-2912F905B8BB

Q33662916-9D621300-9953-474A-9C30-51C027BA7BF5

Q33662916-AD88A51D-86D8-4655-B090-856EF62E3877

P304

Q33662916-2E7993A2-CFD6-41D0-9F96-0A256E61DE3F

P31

Q33662916-9B3D0EA6-B58C-47E6-9C89-5684326E2E2A

P356

Q33662916-AB1C2E35-5EE5-4F30-8D0D-D4C71B96DB6F

P407

Q33662916-9073F738-5DD0-4732-B65F-B20FD6E51393

P433

Q33662916-42EB101A-377D-4304-9BE8-313A1A56244A

P478

Q33662916-B15EF486-A8E2-4DD8-8724-0C94F05B8BA2

P577

Q33662916-C9108CBF-30ED-4E75-9873-9837CA67C532

P5875

Q33662916-BBD877A3-3617-4F1C-A9D0-7915141F06AC

P698

Q33662916-3638455A-D34B-461E-8779-8D9A91FDB7F0

P921

Q33662916-634F5A0B-1E39-440D-A72D-8BD00782DB96

P932

Q33662916-D4EF5011-A0ED-4D06-87B0-2AFB74AB2638

P356

P1433

Archives of Disease in Childhood

P1476

Improved outcome of acute myeloid leukaemia in Down's syndrome.

@en

P2093

Chessells JM

http://www.w3.org/2001/XMLSchema#string

Craze JL

http://www.w3.org/2001/XMLSchema#string

Hann IM

http://www.w3.org/2001/XMLSchema#string

Harrison G

http://www.w3.org/2001/XMLSchema#string

Wheatley K

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity.

Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome.

Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group.

Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group.

Leukemia in Down syndrome: a review.

Prognosis of Down's syndrome with acute leukaemia.

Adverse prognostic features in 251 children treated for acute myeloid leukemia.

P304

32-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ADC.81.1.32

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12926217

http://www.w3.org/2001/XMLSchema#string

P698

10373130

http://www.w3.org/2001/XMLSchema#string

P921

P932

1717984

http://www.w3.org/2001/XMLSchema#string